liver cancer
Helio Genomics Sister Firm LAMH Receives NMPA Approval in China for Blood-Based Liver Cancer Test
The liquid biopsy assay is a modified version of Helio's HelioLiver test that is tailored to the unique genetic makeup of the Asia-Pacific population.
Liver Cancer Detection Score Developed With Machine Learning Analysis of Blood Plasma DNA Fragments
Researchers used machine learning to come up with a cell-free DNA 'fragmentome'-based score for finding hepatocellular carcinoma cases from blood plasma samples.
Ophiomics Liver Cancer Assay Gets CE-IVD Mark
Biocartis is launching the HepatoPredict gene expression assay to help predict the benefits of liver transplant in hepatocellular carcinoma patients.
Genetron Highlights New Minimal Residual Disease Data, Sets Plans for Solid Tumor Testing in China
Premium
The company shared new liver cancer data in a recent journal letter, demonstrating high performance for its tumor-informed approach.
Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials
Premium
As it eyes new targets, the firm is poised to launch its personalized solid tumor MRD assay this year and is progressing toward approval for a liver cancer early detection IVD.